AML1-ETO fusion protein up-regulates TRKA mRNA expression in human CD34+ cells, allowing nerve growth factor-induced expansion.
The AML1-ETO fusion protein, generated by the t(8;21) in acute myeloid leukemia (AML), exerts dominant-negative functions and a variety of gains of function, including a positive effect on the growth of primary human CD34+ hematopoietic stem/progenitor cells. We now show that AML1-ETO expression up-regulates the level of TRKA mRNA and protein in these cells and that AML1-ETO-expressing CD34+ hematopoietic cells grown in the presence of five early-acting hematopoietic cytokines further proliferate in response to nerve growth factor (NGF). These cells also show a unique response to NGF and IL-3; namely, they expand in liquid culture. To determine the biological relevance of our findings, we analyzed 262 primary AML patient samples using real-time RT-PCR and found that t(8;21)-positive AML samples express significantly higher levels of TRKA mRNA than other subtypes of AML. NGF, which is normally expressed by bone marrow stromal cells, could provide important proliferative or survival signals to AML1-ETO-expressing leukemic or preleukemic cells, and the NGF/TRKA signaling pathway may be a suitable target for therapeutic approaches to AML.
Mulloy
James C
JC
Division of Experimental Hematology, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH 45229, USA.
Jankovic
Vladimir
V
Wunderlich
Mark
M
Delwel
Ruud
R
Cammenga
Jorg
J
Krejci
Ondrej
O
Zhao
Hui
H
Valk
Peter J M
PJ
Lowenberg
Bob
B
Nimer
Stephen D
SD
D018952:Antigens, CD34 / Q000276:immunology*; D002455:Cell Division / Q000502:physiology; D050676:Core Binding Factor Alpha 2 Subunit; D005786:Gene Expression Regulation / Q000502:physiology; D006412:Hematopoietic Stem Cells / Q000276:immunology / Q000378:metabolism / Q000502:physiology; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000235:genetics / Q000276:immunology / Q000378:metabolism; D020932:Nerve Growth Factor / Q000378:metabolism*; D015514:Oncogene Proteins, Fusion / Q000235:genetics* / Q000378:metabolism; D000075142:RUNX1 Translocation Partner 1 Protein; D020917:Receptor, trkA / Q000096:biosynthesis / Q000235:genetics*; D014157:Transcription Factors / Q000235:genetics* / Q000378:metabolism; D014178:Translocation, Genetic; D015854:Up-Regulation
C107844:AML1-ETO fusion protein, human; D018952:Antigens, CD34; D050676:Core Binding Factor Alpha 2 Subunit; D015514:Oncogene Proteins, Fusion; D000075142:RUNX1 Translocation Partner 1 Protein; D014157:Transcription Factors; D020932:Nerve Growth Factor; D020917:Receptor, trkA
Cell. 1996 Jan 26;84(2):321-30
8565077
Blood. 2004 Mar 15;103(6):2316-24
14615365
Blood. 1996 Sep 1;88(5):1608-18
8781416
Proc Natl Acad Sci U S A. 1996 Oct 15;93(21):11895-900
8876234
Proc Natl Acad Sci U S A. 1996 Oct 29;93(22):12359-63
8901586
Cell. 1996 Nov 15;87(4):697-708
8929538
Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):14059-64
8943060
J Androl. 1996 Sep-Oct;17(5):481-90
8957691
Proc Natl Acad Sci U S A. 1997 May 27;94(11):5697-702
9159135
Blood. 1998 May 1;91(9):3134-43
9558367
Proc Natl Acad Sci U S A. 1998 Sep 1;95(18):10860-5
9724795
Mol Cell Biol. 1998 Dec;18(12):7176-84
9819404
Mol Cell Biol. 1998 Dec;18(12):7185-91
9819405
Blood. 1999 Feb 15;93(4):1355-63
9949179
Am J Pathol. 1999 Feb;154(2):405-15
10027399
Blood. 1999 Mar 15;93(6):1817-24
10068652
Oncogene. 1999 Mar 4;18(9):1701-10
10208431
Nat Genet. 1999 Oct;23(2):166-75
10508512
J Biol Chem. 2000 Jan 7;275(1):651-6
10617663
Mol Cell Biol. 2000 Mar;20(6):2075-86
10688654
EMBO J. 2000 Apr 17;19(8):1827-38
10775267
Blood. 2000 Jul 15;96(2):655-63
10887131
Blood. 2000 Sep 15;96(6):2108-15
10979955
Blood. 2000 Oct 15;96(8):2862-9
11023523
Mol Cell Biol. 2000 Dec;20(23):8655-66
11073967
Semin Cell Dev Biol. 2000 Oct;11(5):347-60
11105899
Proc Natl Acad Sci U S A. 2001 Apr 24;98(9):5116-21
11309499
Proc Natl Acad Sci U S A. 2001 Aug 28;98(18):10398-403
11526243
Curr Opin Hematol. 2001 Jul;8(4):192-6
11561154
Blood. 2002 Jan 1;99(1):15-23
11756147
Science. 2002 Apr 19;296(5567):497
11964471
Oncogene. 2002 May 13;21(21):3422-44
12032780
Cancer Cell. 2002 Feb;1(1):63-74
12086889
Nat Med. 2002 Jul;8(7):743-50
12091906
Mol Cell Biol. 2002 Aug;22(15):5506-17
12101243
J Exp Med. 2002 Nov 4;196(9):1227-40
12417632
Cell. 2002 Nov 27;111(5):621-33
12464175
Mol Cell Biol. 2004 Apr;24(7):2890-904
15024077
N Engl J Med. 2004 Apr 15;350(16):1617-28
15084694
EMBO J. 1993 Jul;12(7):2715-21
8334990
Blood. 1993 Aug 1;82(3):712-5
8338940
Blood. 1994 Mar 15;83(6):1479-85
8123839
Mol Cell Biol. 1995 Apr;15(4):1974-82
7891692
Oncogene. 1995 Dec 21;11(12):2667-74
8545124
Blood. 2003 Jan 15;101(2):673-80
12393679
Blood. 2003 Mar 15;101(6):2206-14
12406909
Proc Natl Acad Sci U S A. 2003 Aug 5;100(16):9506-11
12881486
Front Biosci. 2003 Sep 1;8:s1181-6
12957860
Blood. 2003 Dec 15;102(13):4369-76
12946995
J Clin Invest. 2003 Dec;112(11):1751-61
14660751
Proc Natl Acad Sci U S A. 1996 Apr 16;93(8):3444-9
8622955